CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online 2016 June 15 DOI: https://doi.org/10.3350/cmh.2015.0053

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clinical and Molecular Hepatology. 2016;22(2):241-249

Link1

Link2 Link3

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clinical and Molecular Hepatology. 2015;21(3):242

Link1 Link2 Link3

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clinical and Molecular Hepatology. 2016;22(4):439-442

Link1

Link2 Link3

Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures

Qian Zhang, Tao Han, Cai-Yun Nie, Fu-Shuang Ha, Lei Liu, Hua Liu

Journal of Medical Virology. 2015;87(6):1013-1021

Link1 Link2

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Byoung Kuk Jang

Clinical and Molecular Hepatology. 2020;26(3):312-314

Link1

Link2 Link3

Tenofovir Disoproxil Fumarate Monotherapy is Superior to Entecavir-Adefovir Combination Therapy in Patients with Suboptimal Response to Lamivudine-Adefovir Therapy for Nucleoside-Resistant HBV: A 96-Week Prospective Multicentre Trial

Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim, Baek Gyu Jun, Young Don Kim, Dae Won Jun, Joo Hyun Sohn, Tae Yeob Kim, Byung Seok Lee

Antiviral Therapy. 2017;23(3):219-227

Link1 Link2

The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir

E. Sheen, H. N. Trinh, T. T. Nguyen, S. T. Do, P. Tran, H. A. Nguyen, K. K. Nguyen, R. T. Garcia, M. H. Nguyen

Alimentary Pharmacology & Therapeutics. 2011;34(7):767-774

Link1 Link2

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

C. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul, K. R. Reddy

Journal of Viral Hepatitis. 2011;19(3):213-219

Link1 Link2

Tenofovir DF Monotherapy is Superior to Entecavir-Adefovir Combination in Chronic Hepatitis B Patients who Are Suboptimal Responder for Lamivudine-Adefovir Therapy with RT204I/V Mutation: A Interim Analysis of Prospective Multicenter Trial

H.S. Kim, S.H. Lee, S.G. Kim, Y.S. Kim, S.W. Jeong, J.Y. Jang, B.S. Kim, D. Won Jun, T.Y. Kim, J.H. Sohn, Y.D. Kim, G.J. Cheon, B.S. Lee

Journal of Hepatology. 2016;64(2):S589

Link1 Link2

P1064 RANDOMIZED TRIAL OF TENOFOVIR MONOTHERAPY VERSUS TENOFOVIR PLUS ENTECAVIR COMBINATION THERAPY IN CHRONIC HEPATITIS B PATIENTS WITH GENOTYPIC RESISTANCE MUTATIONS TO ADEFOVIR

Y.-S. Lim, B.C. Yoo, K.S. Byun, S.Y. Kwon, Y.J. Kim, J. An, H.C. Lee, Y.S. Lee

Journal of Hepatology. 2014;60(1):S431

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.